Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough



Rating:

Share or cite this content

Citations should be made in the following way:
A. Azim (Southampton(Dorset), United Kingdom), C. Barber (Southampton(Dorset), United Kingdom), K. Gove (Southampton(Dorset), United Kingdom), T. Brown (Southampton(Dorset), United Kingdom), T. Jones (Southampton(Dorset), United Kingdom), S. Elliot (Southampton(Dorset), United Kingdom), A. Chauhan (Southampton(Dorset), United Kingdom), P. Howarth (Southampton(Dorset), United Kingdom). Sputum Interleukin 5 in eosinophilic and non-eosinophilic severe asthma. 3125

Member's Comments

No comment yet.

Related content which might interest you: Induced sputum IL-13 concentration in asthma, COPD and eosinophilic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004 Mechanisms of noneosinophilic asthma Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004 IL-5 and GM-CSF positive cells in induced sputum from asthmatics and patients with non-allergic rhinitis with eosinophilia syndrome (NARES) Source: Eur Respir J 2001; 18: Suppl. 33, 529s Year: 2001 Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Sputum eosinophils and bronchial hyperreactivity in patients with chronic cough Source: Eur Respir J 2005; 26: Suppl. 49, 479s Year: 2005 Predictors of sputum eosinophilia in severe asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 Eosinophilic inflammation in sputum of poorly controlled asthmatics Source: Eur Respir J 2002; 20: 1370-1377 Year: 2002 Eosinophilic and neutrophilic mediators in BAL fluid of atopic and non atopic asthmatic children Source: Annual Congress 2009 - Fiberoptic bronchoscopy in the diagnosis of respiratory diseases in children Year: 2009 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 IFNg, IL4 and TGFb in nasal lavage fluid of perennial allergic rhinitis patients and IL4 and TGFb in induced sputum of atopic asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 735s Year: 2005 Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Sputum CC-chemokines, IL-13 and pulmonary function in allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004 Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Interleukin 18 in the sputum of healthy and COPD smokers: evidence of implication in airway and systemic inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 749s Year: 2007 Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005 Apoptotic response of eosinophils in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 17: 190-194 Year: 2001 Noninvasive assessment of inflammation in severe asthma Source: Eur Respir Mon 2011; 51: 208-217 Year: 2011